European Veterinary
Conference Voorjaarsdagen
April 17-19, 2014, Amsterdam
It took a separate search to find that Dr. Casey is presenting though I can't find a date to see if it is current or from an old presentation. Still no info on any human use study.
Patrick is a Clinician/Scientist residing in Kumeu, Auckland, New Zealand. A Veterinary graduate from Massey University (BVSc, 1988), and graduate from the University of California in 1992 with a Doctor of Philosophy (PhD, Comparative Pathology). During his time in the United States he also completed an Equine Surgical Internship at Hagyard-Davidson and McGee, Lexington, Kentucky, followed by a three year residency programme in Equine Reproduction, with a minor in Equine Medicine at UC Davis. In 1992, 1993, and 1994 he received a post-doctoral fellowship from the Equine Research Laboratory at the University of California, which allowed him to set up with world renowned Professor Liggins at the University of Auckland, New Zealand.
Dr Casey is still on staff at the School of Medicine, University of Auckland, New Zealand and Founding Scientist of privately owned Bio-Technology Companies. Padraig has a strong interest in Fertility and Drug Interactions which has lead his research group to study the Somatotrophic Axis in a Rat model and then the Horse. The central aim was, and is, to understand cellular mitosis which has lead to the current area of work.
Using a unique non-drug based culture system, Dr Casey and his colleagues have been able to successfully re-enter cells into a mitotic cell cycle, thus being able to stimulate cells to grow new tissue for transplantation back to the donor individual. These cells, (New Generation, Therapy Cells) enact in tissue repair and regeneration without any fear of rejection due to their autologous nature.
In his presentation Dr Casey will explain the background and science involved in this new area of regenerative medicine. Using this technique his group has been able to grow tenocytes in vitro to transplant back into areas of tendon rupture to enact healing of the lesion. Now that this technique is being used commercially internationally, he will present the very positive clinical findings to date and discuss the possibilities of using this technique to grow many other types of cells for tissue and organ transplantation to enact regeneration and repair.
